Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Epigenetic field cancerization in breast cancer using subject-matched tumor, ipsilateral-normal, and contralateral-normal tissues

View ORCID ProfileMeghan E. Muse, Alexander J. Titus, Lucas A. Salas, Owen M. Wilkins, Chelsey Mullen, Kelly J. Gregory, Sallie S. Schneider, Giovanna M. Crisi, Rahul M. Jarwale, Christopher N. Otis, View ORCID ProfileBrock C. Christensen, View ORCID ProfileKathleen F. Arcaro
doi: https://doi.org/10.1101/19002014
Meghan E. Muse
1Department of Epidemiology, Dartmouth Geisel School of Medicine, Hanover, NH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Meghan E. Muse
Alexander J. Titus
1Department of Epidemiology, Dartmouth Geisel School of Medicine, Hanover, NH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucas A. Salas
1Department of Epidemiology, Dartmouth Geisel School of Medicine, Hanover, NH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Owen M. Wilkins
1Department of Epidemiology, Dartmouth Geisel School of Medicine, Hanover, NH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chelsey Mullen
2Department of Veterinary & Animal Sciences, University of Massachusetts, Amherst, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly J. Gregory
3Pioneer Valley Life Sciences Institute, Baystate Medical Center, Springfield, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sallie S. Schneider
2Department of Veterinary & Animal Sciences, University of Massachusetts, Amherst, MA
3Pioneer Valley Life Sciences Institute, Baystate Medical Center, Springfield, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanna M. Crisi
4Department of Pathology, University of Massachusetts Medical School-Baystate Health, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rahul M. Jarwale
4Department of Pathology, University of Massachusetts Medical School-Baystate Health, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher N. Otis
4Department of Pathology, University of Massachusetts Medical School-Baystate Health, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brock C. Christensen
1Department of Epidemiology, Dartmouth Geisel School of Medicine, Hanover, NH
5Department of Molecular & Systems Biology, Dartmouth Geisel School of Medicine, Hanover, NH
6Department of Community & Family Medicine, Dartmouth Geisel School of Medicine, Hanover, NH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brock C. Christensen
Kathleen F. Arcaro
2Department of Veterinary & Animal Sciences, University of Massachusetts, Amherst, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathleen F. Arcaro
  • For correspondence: karcaro{at}umass.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Emerging work has demonstrated that histologically normal (non-tumor) tissue adjacent to breast tumor tissue shows evidence of molecular alterations related to tumorigenesis, referred to as field cancerization effects. Although changes in DNA methylation are known to occur early in breast carcinogenesis and the landscape of breast tumor DNA methylation is profoundly altered compared with normal tissue, there have been limited efforts to identify DNA methylation field cancerization effects in histologically normal breast tissue adjacent to tumor.

Methods Matched tumor, histologically normal tissue of the ipsilateral breast (ipsilateral-normal), and histologically normal tissue of the contralateral breast (contralateral-normal) were obtained from nine women undergoing bilateral mastectomy. Laser capture microdissection was used to select breast epithelial cells from normal tissues, and neoplastic cells from tumor specimens for genome-scale measures of DNA methylation with the Illumina HumanMethylationEPIC array.

Results We identified substantially more CpG loci that were differentially methylated between contralateral-normal breast and tumor tissue (63,271 CpG loci q < 0.01), than between ipsilateral-normal tissue and tumor (38,346 CpG loci q < 0.01). In addition, we identified differential methylation in ipsilateral-normal relative to contralateral-normal tissue (9,562 CpG loci p < 0.01). Hypomethylated loci in ipsilateral normal relative to contralateral were significantly enriched for breast cancer-relevant transcription factor binding sites including those for ESR1, FoxA1, and GATA3. Hypermethylated loci in ipsilateral-normal relative to contralateral-normal tissue were significantly enriched for CpG island shore regions.

Conclusions Our results indicate that early hypermethylation events in breast carcinogenesis are more likely to occur in the regions immediately surrounding CpG islands than CpG islands per se, reflecting a field effect of the tumor on surrounding histologically normal tissue. This work offers an opportunity to focus investigations of early DNA methylation alterations in breast carcinogenesis and potentially develop epigenetic biomarkers of disease risk.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by funds of the Burroughs-Wellcome/Dartmouth Big Data in the Life Sciences Training Program to MEM. Office of the U.S. Director of the National Institutes of Health under award number T32LM012204 to AJT. COBRE Center for Molecular Epidemiology at Dartmouth P20GM104416, and R01CA216265 to BCC. NIEHS P01ES022832 and EPA RD83544201. R01CA230478-01A1 and ROH-BCR151672 to KFA.

Author Declarations

All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.

Not Applicable

I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.

Not Applicable

Data Availability

The datasets generated and analyzed during the current study are available in the Gene Expression Omnibus under the accession number GSE133985 (https://www.ncbi.nlm.nih.gov/geo/).

  • Abbreviations

    DCIS
    ductal carcinoma in situ
    GO
    gene ontology; OR: odds ratio
    CI
    confidence interval
    TFBS
    transcription factor binding site
    LOLA
    Locus Overlap Analysis
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted July 12, 2019.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Epigenetic field cancerization in breast cancer using subject-matched tumor, ipsilateral-normal, and contralateral-normal tissues
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Epigenetic field cancerization in breast cancer using subject-matched tumor, ipsilateral-normal, and contralateral-normal tissues
    Meghan E. Muse, Alexander J. Titus, Lucas A. Salas, Owen M. Wilkins, Chelsey Mullen, Kelly J. Gregory, Sallie S. Schneider, Giovanna M. Crisi, Rahul M. Jarwale, Christopher N. Otis, Brock C. Christensen, Kathleen F. Arcaro
    medRxiv 19002014; doi: https://doi.org/10.1101/19002014
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Epigenetic field cancerization in breast cancer using subject-matched tumor, ipsilateral-normal, and contralateral-normal tissues
    Meghan E. Muse, Alexander J. Titus, Lucas A. Salas, Owen M. Wilkins, Chelsey Mullen, Kelly J. Gregory, Sallie S. Schneider, Giovanna M. Crisi, Rahul M. Jarwale, Christopher N. Otis, Brock C. Christensen, Kathleen F. Arcaro
    medRxiv 19002014; doi: https://doi.org/10.1101/19002014

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)